| Dr Merle Guzon Ancheta, DDS | |
|
900 Quebec Avenue, Corcoran, CA 93212 | |
| (559) 992-7100 | |
| Not Available |
| Full Name | Dr Merle Guzon Ancheta |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 900 Quebec Avenue, Corcoran, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790968964 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 32260 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Merle Guzon Ancheta, DDS 900 Quebec Avenue, Corcoran, CA 93212 Ph: (559) 992-7100 | Dr Merle Guzon Ancheta, DDS 900 Quebec Avenue, Corcoran, CA 93212 Ph: (559) 992-7100 |
News Archive
A new study in monkeys, published on October 14, 2019, in the Proceedings of the National Academy of Sciences, shows that organisms at the bottom of the social hierarchy live shorter lives. Moreover, they experience more sickness, and may continue to experience health problems despite moving up later. Adverse experiences of social life continue to reflect in their genes much longer than the actual experience, in the form of changes in gene expression via altered gene regulation.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced patient enrollment has commenced in the Company's pivotal VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks) Phase 3 clinical study of varespladib (A-002).
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
Dr Rafael Yáñez-Muñoz, from the School of Biological Sciences at Royal Holloway, University of London, is leading a team of researchers working to develop a novel treatment for spinal cord injury - which leaves sufferers with devastating, life-long effects including paralysis.
› Verified 3 days ago
Dr. Irv M Wilbur, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4001 King Ave, Corcoran, CA 93212 Phone: 559-992-8800 | |
Dr. Michael Anthony Cortez, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 933 Whitley Ave, Corcoran, CA 93212 Phone: 559-762-7587 | |
Dr. Kirk Muno Gerstel, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4001 King Ave, Corcoran, CA 93212 Phone: 559-992-8800 | |
Mr. John Vernon Dale Richardson, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1409 Whitley Ave, Suite D, Corcoran, CA 93212 Phone: 559-992-4138 Fax: 559-992-4079 | |
Dr. Robert Blair Sears, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 900 Quebec Ave, Corcoran, CA 93212 Phone: 503-522-9188 | |
Dr. Hani Makram Guirguis, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 4001 King Ave., Corcoran, CA 93274 Phone: 559-992-8800 | |
Dr. Nicholas Preston Delacruz, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1209 Whitley Ave, Corcoran, CA 93212 Phone: 559-992-5020 |